Skip to Content

FDA panel backs removal of unproven pregnancy drug


AP Health Writer

WASHINGTON (AP) — A panel of federal advisers says a pregnancy drug intended to prevent premature births should be withdrawn because it doesn’t work. Wednesday’s recommendation is non-binding, but it clears the way for the Food and Drug Administration to remove the drug from the market. The FDA deemed the drug ineffective and called for its removal in 2020. But manufacturer Covis Pharma has challenged that decision, setting up this week’s public hearing to discuss the drug. The FDA ‘s commissioner will make a final decision in coming weeks on whether to order a removal. Drugmakers almost always voluntarily remove their drugs at FDA’s request.

Article Topic Follows: AP National

Jump to comments ↓

Author Profile Photo

Associated Press


KIFI Local News 8 is committed to providing a forum for civil and constructive conversation.

Please keep your comments respectful and relevant. You can review our Community Guidelines by clicking here

If you would like to share a story idea, please submit it here.

Skip to content